The Telegraph Examines Testing Of Genetically Modified Mosquitoes In Burkina Faso To Prevent Malaria, Residents’ Opposition To Technique

The Telegraph: ‘We don’t want to be guinea pigs’: how one African community is fighting genetically modified mosquitoes
“…Researchers from the Target Malaria consortium, a not-for-profit research group funded by the Bill & Melinda Gates Foundation and various research institutions, have developed a mosquito in their laboratory that can kill off its own species by spreading a faulty gene. If it works in the wild, the technology — called gene drive — could help eliminate malaria where decades of efforts involving bed nets, repellents, and insecticides have failed. This isn’t the first experiment Burkinabes have witnessed in the fight against one of Africa’s leading killers but it is certainly one of the most radical. … But the move towards genetic modification has unleashed unprecedented opposition in the landlocked West African country. In the summer of 2018, more than 1,000 people marched in the capital Ouagadougou against the use of genetically-modified organisms in the country, including the GM mosquitoes…” (Pujol-Mazzini/Zombre, 10/8).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.